Adjustment for selection bias in observational studies with application to the analysis of autopsy data

Neuroepidemiology

Volumn 32, Issue 3, 2009, Pages 229-239

  Haneuse, S ^a,d   Schildcrout, J ^c   Crane, P ^a,b   Sonnen, J ^a   Breitner, J ^a,b   Larson, E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Alzheimer's disease; Autopsy; Bootstrap; Dementia; Regression analysis; Selection bias; Weighted estimating equations

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; HUMAN; METHODOLOGY; OBSERVATIONAL STUDY; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; AUTOPSY; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MODELS, STATISTICAL; SELECTION BIAS; STATISTICS AS TOPIC;

EID: 58749085584     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000197389     Document Type: Article

References (25)

1. Zaccai J, Ince P, Brayne C: Population-based neuropathological studies of dementia: design, methods and areas of investigation - a systematic review. BMC Neurol 2006;6:2.
2. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, Craft S, Leverenz JB, Montine TJ: Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007;62:406-413.
3. MacClean C, Reed D: Predictors of atherosclerosis in the Honolulu Heart Program. Am J Epidemiol 1987;126:226-236.
4. Gao S, Hui SL, Hall KS, Hendrie HC: Estimating disease prevalence from two-phase surveys with non-response at the second phase. Stat Med 2000;19:2101-2114.
5. Tsuang D, Simpson KL, Li G, Barnhart RL, Edland SD, Bowen J, McCormick W, Teri L, Nochlin D, Larson EB, Thompson ML, Leverenz JB: Evaluation of selection bias in an incident-based dementia autopsy case series. Alzheimer Dis Assoc Disord 2005;19:67-73.
6. Hernán MA, Hernandez-Diaz S, Robins JM: A structural approach to selection bias. Epidemiology 2004;15:615-625.
7. Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB: Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 2002;59:1737-1746.
8. Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, Sugimoto K, Yamaguchi T, Sasaki H, Chiu D, et al: The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 1994;6:45-58, 62.
9. Rothman K, Greenland S: Modern Epidemiology, ed 2. Philadelphia, Lippincott Williams & Wilkins, 1998.
10. Szklo M: Population-based cohort studies. Epidemiol Rev 1998;20:81-90.
11. McCullagh P, Nelder J: Generalized Linear Models, ed 2. Boca Raton, Chapman & Hall/CRC, 1989.
12. Liang K-Y, Zeger S: Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
13. Robins JM, Rotnitzky A, Zhao LP: Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assoc 1994;89:846-866.
14. Little R, Rubin D: Statistical Analysis with Missing Data, ed 2. Hoboken, Wiley, 2002.
15. Efron B, Tibshirani R: An Introduction to Bootstrap. London, Chapman & Hall, 1993.
16. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
17. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, Masaki K, Launer L, Markesbery WR: Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann NY Acad Sci 2002;977:9-23.
18. Braak H, Braak E: Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl 1996;165:3-12.
19. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L: The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol 2000;57:839-844.
20. Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, Welsh-Bohmer KA, Alavi A, Clark CM, Salmon E, de Leon MJ, Mielke R, Cummings JL, Kowell AP, Gambhir SS, Hoh CK, Phelps ME: Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 2001;286:2120-2127.
21. Kemppainen NM, Aalto S, Wilson IA, Nagren K, Helin S, Bruck A, Oikonen V, Kailajarvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO: PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology 2007;68:1603-1606.
22. Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC: [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006;67:446-452.
23. Ellenberg JH: Differential postmorbidity mortality in observational studies of risk factors for neurologic disorders. Neuroepidemiology 1994;13:187-194.
24. Ellenberg JH: Observational data bases in neurological disorders: selection bias and generalization of results. Neuroepidemiology 1994;13:268-274.
25. Riedel-Heller SG, Schork A, Matschinger H, Angermeyer MC: Recruitment procedures and their impact on the prevalence of dementia. Results from the Leipzig Longitudinal Study of the Aged (LEILA75+). Neuroepidemiology 2000;19:130-140.